« Back to Record
Citation APA

Berns, K., Sonnenblick, A., Gennissen, A., Brohée, S., Hijmans, M. E., Evers, B., Fumagalli, D., Desmedt, C., Loibl, S., Denkert, C., Neven, P., Guo, Y.-W., Zhang, F., Knijnenburg, T. T., Bosse, T., van der Heijden, M. M., Hindriksen, S., Nijkamp, W., Wessels, L. F. A., Joensuu, H., Mills, G. B., Beijersbergen, R. R., Sotiriou, C., & Bernards, R. (2016). Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance. Clinical cancer research, 22(21), 5238-5248. doi:10.1158/1078-0432.CCR-15-2996


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/241916

Berns, K., Sonnenblick, A., Gennissen, A., Brohée, S., Hijmans, M. E., Evers, B., Fumagalli, D., Desmedt, C., Loibl, S., Denkert, C., Neven, P., Guo, Y.-W., Zhang, F., Knijnenburg, T. T., Bosse, T., van der Heijden, M. M., Hindriksen, S., Nijkamp, W., Wessels, L. F. A., Joensuu, H., Mills, G. B., Beijersbergen, R. R., Sotiriou, C., & Bernards, R. (2016). Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance. Clinical cancer research, 22(21), 5238-5248. doi:10.1158/1078-0432.CCR-15-2996